✨ Free AI Report
PeptiDream Inc.: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research PeptiDream Inc.
Company Research

PeptiDream Inc.: Business Overview, Financials & Competitive Analysis

PeptiDream engages in the biopharmaceutical business that includes research and development of non-standard peptide therapeutics. The company is largely credited with establishing the macrocyclic peptide field with hi...

Analyst-debate audio for PeptiDream Inc.

AskCyborg analysts argue the bull and bear cases for PeptiDream Inc. across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
7/ 10Strong

Cyborg Score thesis

With revenue growing, losses narrowing and the share price trading at steep discount to analyst targets, PeptiDream presents...

Read the full analyst-debate transcript →
Industry Biopharmaceutical - Drug Discovery and Development (Peptide Therapeutics)
2 named competitors
3 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: October 19, 2026
AI-Generated Research
30+ Page Report

Get the Latest PeptiDream Inc. Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

PeptiDream Inc. Overview

Pro stress-test →

PeptiDream engages in the biopharmaceutical business that includes research and development of non-standard peptide therapeutics. The company is largely credited with establishing the macrocyclic peptide field with high global reputation across the pharma industry.

Strategic Profile

Pro stress-test →

The company develops its products based on its Peptide Discovery Platform System, a drug finding platform that enables the production of non-standard peptide libraries for the identification of potent and selective macrocyclic peptide candidates. Revenue generation is predominantly through strategic collaborations with leading global pharmaceutical companies, licensing access to its PDPS technology and collaborating on drug discovery projects, securing upfront payments, research funding, milestone payments, and potential royalties.

Competitive Landscape

Pro stress-test →

PeptiDream is positioned as the global leader in peptide therapeutics discovery, established in 2006 and credited with establishing the macrocyclic peptide field. The company faces competition from emerging biotech firms, but maintains strategic advantages through its proprietary PDPS platform, extensive pharma partnerships, and integrated radiopharmaceutical subsidiary (PDRadiopharma).

Industry Context

PeptiDream Inc. operates in Biopharmaceutical - Drug Discovery and Development (Peptide Therapeutics).

Key facts

Founded: 2006 · Headquarters: Kawasaki, Japan · Employees: 750+ · Revenue: $323.0M (2024) · Market cap: $1.4B USD (244.8B JPY as of March 2026)

What the AI analysts debated

AI-generated and not independently verified: selected findings from the multi-agent debate on PeptiDream Inc..

  • 2024 revenue reached $323.0M with 62.6% YoY growth.
  • The company has 750+ employees spanning discovery, development, manufacturing, regulatory, and sales across the PeptiDream Group including PDRadiopharma subsidiary.
+2 more AI-generated counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • December 2025Advanced oral dual IL-17 program into clinical portfolio and achieved siRNA delivery milestone with Alnylam
  • May 2024Expanded peptide discovery collaboration with Novartis in $2.7B deal
  • +1 moreTrack every material event for PeptiDream Inc. as it happens. Explore monitoring →
Get alerted when PeptiDream Inc. has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Constrained Peptide Drug DiscoveryCompetitor in peptide-based drug discovery→Macrocyclic Peptide TherapeuticsVarious competitors in peptide drug space→

Compare PeptiDream Inc. with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

PeptiDream Inc. operates in Biopharmaceutical - Drug Discovery and Development (Peptide Therapeutics). See how the rest of the sector scores on the Cyborg framework.

Browse Biopharmaceutical - Drug Discovery and Development (Peptide Therapeutics) research →
NEW · MCP server

Ask your AI assistant about PeptiDream Inc.

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare PeptiDream Inc. and its top competitor on Cyborg Score”
“What did PeptiDream Inc. do this quarter?”
“Is PeptiDream Inc. a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg research is made

⚔

AI analyst debate, not single-author opinion

Every report is generated by a panel of AI analysts arguing across 11 dimensions, so counter-arguments sit alongside the case. The debate is a reasoning process; it does not independently verify facts.

📊

Dated, not live

The Cyborg Score and recent developments reflect public sources as of the date shown and can miss or lag recent events. Check primary sources before relying on them.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The Cyborg Score is an AI-generated opinion under that framework, not a credit rating or an investment recommendation.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, and news flow, analysed by AI models. Read the methodology →

AI-generated research summary based on public sources; it may contain errors or omissions. Not investment advice. Not reviewed or endorsed by the companies covered. Report an error: legal@askcyborg.com · Terms of Service

Frequently asked questions

What does PeptiDream Inc. do?+
PeptiDream engages in the biopharmaceutical business that includes research and development of non-standard peptide therapeutics. The company is largely credited with establishing the macrocyclic peptide field with hi...
What is PeptiDream Inc.'s Cyborg Score?+
PeptiDream Inc. has a Cyborg Score of 7/10 (Strong). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are PeptiDream Inc.'s main competitors?+
Named competitors include Constrained Peptide Drug Discovery, Macrocyclic Peptide Therapeutics. The full competitive landscape is in the AskCyborg report.
How can I get the full PeptiDream Inc. research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the PeptiDream Inc. research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track PeptiDream Inc. over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

Top-scored companies on AskCyborg

The strongest performers across the analyst-debate framework.

9Advantest Corporation9Anthropic9Apple Inc.9Applied Materials, Inc.9Arista Networks9Aritzia Inc.9ASML Holding N.V.9BAE Systems plc9Barrick Mining Corporation9Berkshire Hathaway Inc.